WOOP there it is: mental strategy boosts weight loss in vets
NCT ID NCT05014984
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a mental strategy called WOOP (Wish, Outcome, Obstacle, Plan) to help veterans with obesity lose weight. Over 400 veterans were split into two groups: one got the VA's standard weight program (MOVE!) plus WOOP, the other got MOVE! alone. The goal was to see if adding WOOP led to more weight loss over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- mental contrasting with implementation intentions (WOOP)
- What this could lead to
- If it works, this could offer a simple, low-cost tool to help veterans with obesity lose more weight and keep it off.
- What could go wrong
- This is a completed trial, but the approach is behavioral and results may vary. It may not work for everyone, and long-term weight loss is hard to maintain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
405 people
The number who actually took part.
- Started
-
Feb 2022
- Finished
-
Feb 2026
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18-70 (this age range represents MOVE!/TeleMOVE! eligibility); * The most recent BMI of 30kg/m2 (with or without obesity-associated comorbidities) OR a BMI of 25kg/m2 with obesity-associated condition (heart diseases, hyperlipidemia, hypertension, cancer, diabetes, stroke, or osteoarthritis); * at least 1 prior PCP visit in the past 24 months; access to a telephone; ability to travel to Manhattan VA for in-person evaluations at baseline, 6 and 12 months; * desire to lose weight (Using 1-10 scale used in PI's other studies; minimum of 5/10); * willingness to enroll in the MOVE!/TeleMOVE! program or any local/national VA program that support weight management. Exclusion Criteria: * Non-Veterans; * a documented current history of active psychosis or other cognitive issues via ICD-10 codes; * Diagnosed with Parkinson's disease and/or severe arthritis that might require joint or knee replacement in the next year; * participating in a weight management study in the past year; * taking an FDA-approved weight loss medication; Bupropion-naltrexone (Contrave) Liraglutide (Saxenda) Orlistat (Xenical)/alli Phentermine-topiramate (Qsymia) Phentermine Topiramate Lorcaserin / Belviq glucagon-like peptide 1 (GLP-1) agonists: Diabetes drugs in the GLP-1 agonists class include: Dulaglutide (Trulicity) Exenatide extended release (Bydureon) Exenatide (Byetta) Semaglutide (Ozempic) Semaglutide (Rybelsus) Liraglutide (Victoza) Lixisenatide (Adlyxin) Metformin to lose weight not for your diabetes; * pregnancy; * PCP stating that Veteran should not participate. * Seeing a dietitian or MOVE!/TeleMOVE! Program attendance more than 3 times in the past year. * Hospitalization within 90 days of enrollment. * Anyone who is included in Dr. Jose Aleman weight management clinic
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obesity are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA NY Harbor Healthcare System, New York, NY
New York, New York, 10010-5011, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can electrical muscle stimulation boost exercise benefits after menopause?
- Can a cold cloth on the neck calm Post-Surgery nausea?